Market Value2,645,070,547
Total Holdings59
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RNA / Avidity Biosciences, Inc.
KYTX / Kyverna Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
XNCR / Xencor, Inc.
ARVN / Arvinas, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
PFE / Pfizer Inc. Call
TECX / Tectonic Therapeutic, Inc.
DNA / Ginkgo Bioworks Holdings, Inc.
SRPT / Sarepta Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ALGS / Aligos Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
IMNM / Immunome, Inc.
MRSN / Mersana Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
AVIR / Atea Pharmaceuticals, Inc.
PRTA / Prothena Corporation plc
HOOK / HOOKIPA Pharma Inc.
DYN / Dyne Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
NUVB / Nuvation Bio Inc.
ALLK / Allakos Inc.
LENZ / LENZ Therapeutics, Inc.
MBX / MBX Biosciences, Inc.
PRQR / ProQR Therapeutics N.V.
MLTX / MoonLake Immunotherapeutics
ARTV / Artiva Biotherapeutics, Inc.
GBIO / Generation Bio Co.
KYMR / Kymera Therapeutics, Inc.
WHWK / Whitehawk Therapeutics, Inc.
PRME / Prime Medicine, Inc.
ALVR / AlloVir, Inc.
RLAY / Relay Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
SWTX / SpringWorks Therapeutics, Inc.
CRGX / CARGO Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
DSGN / Design Therapeutics, Inc.
REPL / Replimune Group, Inc.
KURA / Kura Oncology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
NGNE / Neurogene Inc.
QURE / uniQure N.V. Call
QURE / uniQure N.V.
ETON / Eton Pharmaceuticals, Inc. Call
CRNX / Crinetics Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
ITOS / iTeos Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc. Call
VRDN / Viridian Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PHVS / Pharvaris N.V.
DAWN / Day One Biopharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
VYGR / Voyager Therapeutics, Inc.
UPB / Upstream Bio, Inc.
FATE / Fate Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
ZYME / Zymeworks Inc.
ATRA / Atara Biotherapeutics, Inc.
ETON / Eton Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
TCRX / TScan Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.